Syngene International Ltd.

₹632.7

Syngene International Ltd.

Add Alert
Add Watchlist

₹632.7

₹632.7

-1.8 (-0.28%) - 7 Oct 2025 04:15 PM

About Company

Syngene International Limited, incorporated in 1993, is an internationally reputed contract research and manufacturing organization, which supports R&D programs from lead generation to clinical supplies. The company’s multi-disciplinary skills in integrated drug discovery and development include capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with Clinical development services. The company has state-of-the-art research facilities certified with ISO 9001:2008, ISO 14001:2004, and OHSAS 18001:2007. The company’s animal facilities are GLP certified by the Indian authorities and AAALAC accredited.

Market Cap. ₹ 25,494 Cr.
52 Week - High/Low ₹ 961/600
P/E Ratio 54.40
P/B Ratio 5.50
Enterprise Value ₹ 25,251 Cr.
ROE % 10.65
RSI Value 44.24
EMA 50 649.87
EMA 200 690.94
Market Cap. ₹ 25,494 Cr.
52 Week - High/Low ₹ 961/600
P/E Ratio 50.21
P/B Ratio 5.39
Enterprise Value ₹ 25,350 Cr.
ROE % 11.23
RSI Value 44.24
EMA 50 649.87
EMA 200 690.94

Valuation

Calculators

Peer Comparison

Industry - Business Support

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.